Probiotic supplement for advanced lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial tests if taking a probiotic supplement along with your standard lung cancer treatment can help you live longer and respond better to therapy. It is for people with advanced non-small cell lung cancer who have not tried immunotherapy before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-small cell lung cancer that is advanced or has spread (Stage IV).
- You are at least 18 years old and willing to join the trial.
- You have not received any immunotherapy (like Keytruda, Opdivo, or Yervoy) before.
- You do not currently take probiotics or regular antibiotics, and you have not taken antibiotics in the past month.
- You do not take high-dose daily steroids (more than 10 mg prednisone) and do not have serious heart, lung, or adrenal problems.
- You are not pregnant, breastfeeding, or have a history of interstitial lung disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new study drug called PF-08634404 combined with standard chemotherapy for people with advanced lung cancer that has not been treated before. It aims to see if this combination works better than chemotherapy alone.
This study tests whether a probiotic supplement (LR607) can help patients with newly diagnosed non-small cell lung cancer—a common type of lung cancer. Probiotics are beneficial bacteria that may help your immune system fight cancer alongside standard treatments.
This trial tests whether adding a probiotic (Lactobacillus Johnsonii) to standard chemotherapy and immunotherapy can help people with certain advanced solid tumors that have stopped responding to prior immunotherapy. It may help your immune system work better against the cancer.
This trial tests a combination of a probiotic (Lactobacillus johnsonii), two chemotherapy drugs (CapeOX), and an immunotherapy (pembrolizumab) for people with a specific type of advanced colorectal cancer that has not responded to previous treatments. It aims to see if this mix can help control the cancer.
This trial tests whether a postbiotic supplement can help people with advanced non-small-cell lung cancer who are losing weight (cachexia). If you're getting or have finished chemotherapy plus immunotherapy for stage III or IV NSCLC and have lost weight recently, you may be able to join.
This trial tests whether adding a fiber supplement to standard immunotherapy can help treat advanced non-small cell lung cancer. It's for people whose tumors have high PD-L1 levels and no treatable genetic mutations.
Hear when a new Metastatic Non-small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.